{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:56:21Z","timestamp":1788519381964,"version":"build-2803163510"},"reference-count":187,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["ASSAY and Drug Development Technologies"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>Drug delivery systems are now being advanced by integrating sophisticated nanotechnologies to enhance therapeutic efficacy. Tremendous advancement has been achieved in the field of cancer therapy through the utilization of hyaluronic acid-based nanocarriers, which are well-acknowledged for their capacity to transport medication precisely to targeted regions. Quantum dots exhibit unique optical properties that allow for precise drug administration and monitoring capabilities. Carbon nanotubes provide a large surface area and exceptional strength, allowing for precise manipulation of drug delivery patterns. Dendrimers are versatile structures that can transport many drugs simultaneously, whereas mesoporous silica-functionalized nanoparticles allow exact manipulation of the release rate of pharmaceuticals. Polymer-lipid hybrid nanoparticles synergistically integrate the durability of polymers with the compatibility of lipids, hence augmenting the availability of drugs within the body. Hexagonal boron nitride nanosheets are becoming more recognized as favorable carriers due to their biocompatibility and potential for tailored administration. These achievements demonstrate the changes happening in the field of pharmaceutical administration, where nanotechnology is used to tackle issues such as restricted bioavailability and unanticipated adverse effects. This ultimately enhances the effectiveness of medicines and improves patient outcomes. Future investigations will focus on improving these technologies for broader therapeutic applications.<\/jats:p>","DOI":"10.1089\/adt.2025.031","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T08:16:41Z","timestamp":1746605801000},"page":"2-29","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent Trends in Drug Delivery Systems"],"prefix":"10.1177","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-5649","authenticated-orcid":false,"given":"Omnia Mohamed","family":"Sarhan","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Badr University in Cairo (BUC), Cairo, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"1","key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/723178","article-title":"Nanotechnologies for curcumin: An ancient puzzler meets modern solutions","volume":"2011","author":"Wang S","year":"2011","unstructured":"Wang S, , Tan M, , Zhong Z, et al. Nanotechnologies for curcumin: An ancient puzzler meets modern solutions. Journal of Nanomaterials, 2011; 2011(1):1\u20138.","journal-title":"Journal of Nanomaterials"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2011.08.030"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043384826"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2010.02.002"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-00477-3_15"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-chembioeng-073009-100847"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.09.020"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.07.004"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040269"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0403-50"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.4103\/0975-8453.86297"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-021-00416-6"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/polym15102317"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.01.033"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.532457"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010103"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.2174\/0115672018275983231207101222"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.990145"},{"key":"e_1_3_5_20_2","first-page":"51","article-title":"In vitro study of the gel cohesivity and persistence to hyaluronidase degradation of a novel stabilized composition of 26 mg\/mL of high molecular weight HA","volume":"11","author":"Finke A","year":"2024","unstructured":"Finke A, , B\u00e9temps J Bon, , Molliard S Gavard. In vitro study of the gel cohesivity and persistence to hyaluronidase degradation of a novel stabilized composition of 26 mg\/mL of high molecular weight HA. Plast Aesthet Res, 2024; 11:51.","journal-title":"Plast Aesthet Res"},{"issue":"7","key":"e_1_3_5_21_2","first-page":"204","article-title":"Biocompatible osimertinib nanoliposomes coated with PEGylated hyaluronic acid enhanced tumor selectivity and cytotoxicity via CD44-mediated NSCLC targeting: Development, characterization and in-vitro biochemical studies","volume":"13","author":"Kuna SK","year":"2023","unstructured":"Kuna SK, , Choppala AD. Biocompatible osimertinib nanoliposomes coated with PEGylated hyaluronic acid enhanced tumor selectivity and cytotoxicity via CD44-mediated NSCLC targeting: Development, characterization and in-vitro biochemical studies. J Applied Pharmaceutical Science, 2023; 13(7):204\u2013213.","journal-title":"J Applied Pharmaceutical Science"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2222"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213865"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118294"},{"issue":"5","key":"e_1_3_5_25_2","first-page":"201","article-title":"Strategies of hyaluronan chemical modifications for biomedical applications","volume":"68","author":"Trifan SI","year":"2023","unstructured":"Trifan SI, , Ivanov D, , \u201cPetru Poni\u201d Institute of Macromolecular Chemistry, Romanian Academy, Aleea Grigore Ghica Voda 41-A, RO-700487 Ia\u015fi, Romania. Strategies of hyaluronan chemical modifications for biomedical applications. RevRoumChim, 2023; 68(5\u20136):201\u2013207.","journal-title":"RevRoumChim"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.202300599"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1039\/D4NR00426D"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.4103\/JCRP.JCRP_13_20"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713048"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2022.3380"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1063\/5.0228610"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1063\/5.0129108"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1108\/TQM-06-2022-0186"},{"key":"e_1_3_5_34_2","first-page":"280","article-title":"Advanced manufacturing with machine learning: Enhancing predictive maintenance, quality control, and process optimization","author":"Ani O","year":"2024","unstructured":"Ani O. Advanced manufacturing with machine learning: Enhancing predictive maintenance, quality control, and process optimization. Al-Rafidain Journal of Engineering Sciences, 2024:280\u2013300.","journal-title":"Al-Rafidain Journal of Engineering Sciences"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00334"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.648"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112346"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500439"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574892818666230215112942"},{"key":"e_1_3_5_40_2","article-title":"Exploring the potentials of hyaluronic acid-coated polymeric nanoparticles in enhanced cancer treatment by precision drug delivery, tackling drug resistance, and reshaping the tumour micro environment","author":"Raval H","year":"2024","unstructured":"Raval H, , Bhattacharya S. Exploring the potentials of hyaluronic acid-coated polymeric nanoparticles in enhanced cancer treatment by precision drug delivery, tackling drug resistance, and reshaping the tumour micro environment. Curr Med Chem, 2024.","journal-title":"Curr Med Chem"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.30574\/wjbphs.2024.20.1.0791"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131920"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2020.107950"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1041203"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.63221"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.18433\/J3K89D"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.895406"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0038-1098(85)80025-9"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano12203706"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101052"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eti.2020.101067"},{"key":"e_1_3_5_52_2","volume-title":"Nanomaterials: Synthesis, Characterization, Hazards and Safety","author":"Tahir MB","year":"2021","unstructured":"Tahir MB, , Sagir M, , Asiri AM. Nanomaterials: Synthesis, Characterization, Hazards and Safety. Elsevier; 2021."},{"key":"e_1_3_5_53_2","first-page":"231","article-title":"Opioid oral and analgesics injectable see progesterone-only pain contraceptives combined oral contraceptives medroxyprogesterone acetate (X) 10 mg daily x 10-13 days Provera Tab: 2.5, 5, 10 mg","volume":"2021","author":"t Corticosteroids DYSHIDROSIS T","year":"2022","unstructured":"t Corticosteroids DYSHIDROSIS T. Opioid oral and analgesics injectable see progesterone-only pain contraceptives combined oral contraceptives medroxyprogesterone acetate (X) 10 mg daily x 10-13 days Provera Tab: 2.5, 5, 10 mg. APRN and PA\u2019s Complete Guide to Prescribing Drug Therapy, 2022; 2021:231.","journal-title":"APRN and PA\u2019s Complete Guide to Prescribing Drug Therapy"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2018.1473409"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2015.1102740"},{"issue":"3","key":"e_1_3_5_56_2","first-page":"885","article-title":"Biomedical and biological applications of quantum dots","volume":"44","author":"Abbasi E","year":"2016","unstructured":"Abbasi E, , Kafshdooz T, , Bakhtiary M, et al. Biomedical and biological applications of quantum dots. Artif Cells Nanomed Biotechnol, 2016; 44(3):885\u2013891.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.3390\/nano13212889"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp025698c"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/26\/29\/295701"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1088\/2050-6120\/aaf6f8"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms10020441"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.2174\/97816810851801170101"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja301332t"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp5064325"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/ma17092152"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2010.526227"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102436"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01240-z"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202401631"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S299448"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2021.644564"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101811"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101855"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567201817999200508092821"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052640"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1039\/D1TB01242H"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2008.111"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370490439597"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00084.2005"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2005.10.005"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/10643389.2023.2279894"},{"issue":"2","key":"e_1_3_5_82_2","first-page":"133","article-title":"Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen","volume":"62","author":"Elsayed MM","year":"2007","unstructured":"Elsayed MM, , Abdallah O, , Naggar V, et al. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Die Pharmazie-An International Journal of Pharmaceutical Sciences, 2007; 62(2):133\u2013137.","journal-title":"Die Pharmazie-An International Journal of Pharmaceutical Sciences"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1039\/b309043b"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/jctb.464"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.03.100"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.2741\/2774"},{"key":"e_1_3_5_87_2","first-page":"692","volume-title":"Synthesis, Characterization, and Applications of Dendrimer-encapsulated Nanoparticles","author":"Scott RW","year":"2005","unstructured":"Scott RW, , Wilson OM, , Crooks RM. Synthesis, Characterization, and Applications of Dendrimer-encapsulated Nanoparticles. ACS Publications; 2005; pp. 692\u2013704."},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-022-00298-5"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1409"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1039\/c3tb20724b"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10904-021-01925-2"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.19163\/2307-9266-2021-9-1-4-16"},{"key":"e_1_3_5_93_2","unstructured":"Kannan R. editor. Design of dendrimer-based drug delivery nanodevices with enhanced therapeutic efficacies. In: APS March Meeting Abstracts; 2007."},{"key":"e_1_3_5_94_2","volume-title":"Dendrimer-based Nanotherapeutics","author":"Kesharwani P","year":"2021","unstructured":"Kesharwani P. Dendrimer-based Nanotherapeutics. Academic Press; 2021."},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127564"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104216"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2005.09.019"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp9106052"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10895-009-0532-5"},{"key":"e_1_3_5_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2009.10.023"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1258"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.08.031"},{"issue":"1","key":"e_1_3_5_103_2","first-page":"16","article-title":"Dendrimer chemistry and host-guest interactions for drug targeting","volume":"5","author":"Tripathy S","year":"2014","unstructured":"Tripathy S, , Baro L, , Das MK. Dendrimer chemistry and host-guest interactions for drug targeting. Int J Pharmaceutical Sci Res, 2014; 5(1):16.","journal-title":"Int J Pharmaceutical Sci Res"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173982"},{"key":"e_1_3_5_105_2","first-page":"143","volume-title":"Frontiers of Nanoscience","author":"S\u00e1nchez-Navarro M","year":"2012","unstructured":"S\u00e1nchez-Navarro M, , Rojo J. Synthetic strategies to create dendrimers: Advantages and drawbacks. In: Frontiers of Nanoscience. Elsevier; 2012; pp. 143\u2013156."},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780162999"},{"key":"e_1_3_5_107_2","first-page":"108","article-title":"Surface modification of cationic dendrimers eases drug delivery of anticancer drugs","volume":"10","author":"Karthikeyan R","year":"2016","unstructured":"Karthikeyan R, , Koushik O, , Kumar V. Surface modification of cationic dendrimers eases drug delivery of anticancer drugs. Nanosci Nanotechnol, 2016; 10:108.","journal-title":"Nanosci Nanotechnol"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.3c00263"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.1039\/D0NR02614J"},{"key":"e_1_3_5_110_2","doi-asserted-by":"publisher","DOI":"10.3390\/ma13010065"},{"key":"e_1_3_5_111_2","doi-asserted-by":"publisher","DOI":"10.17480\/psk.2023.67.6.342"},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.1039\/c1cc11760b"},{"key":"e_1_3_5_113_2","doi-asserted-by":"publisher","DOI":"10.1039\/c0jm00554a"},{"key":"e_1_3_5_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2012.02.046"},{"key":"e_1_3_5_115_2","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201902634"},{"key":"e_1_3_5_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmat3776"},{"key":"e_1_3_5_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01654-7"},{"key":"e_1_3_5_118_2","doi-asserted-by":"publisher","DOI":"10.1021\/jz300021x"},{"key":"e_1_3_5_119_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja065485r"},{"key":"e_1_3_5_120_2","doi-asserted-by":"publisher","DOI":"10.1039\/D3AY01493B"},{"key":"e_1_3_5_121_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.8b03337"},{"key":"e_1_3_5_122_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7NR05762H"},{"key":"e_1_3_5_123_2","doi-asserted-by":"publisher","DOI":"10.1088\/2053-1591\/abbf7e"},{"key":"e_1_3_5_124_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx300166u"},{"key":"e_1_3_5_125_2","doi-asserted-by":"publisher","DOI":"10.1002\/asia.201100710"},{"key":"e_1_3_5_126_2","doi-asserted-by":"publisher","DOI":"10.1039\/D1CC03011F"},{"key":"e_1_3_5_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2018.10.039"},{"key":"e_1_3_5_128_2","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/22\/50\/505702"},{"key":"e_1_3_5_129_2","doi-asserted-by":"publisher","DOI":"10.1021\/acssuschemeng.2c06447"},{"key":"e_1_3_5_130_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c03406"},{"key":"e_1_3_5_131_2","doi-asserted-by":"publisher","DOI":"10.1021\/jz9002108"},{"key":"e_1_3_5_132_2","doi-asserted-by":"publisher","DOI":"10.1088\/2515-7639\/ac2b87"},{"key":"e_1_3_5_133_2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202101589"},{"key":"e_1_3_5_134_2","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202101409"},{"key":"e_1_3_5_135_2","doi-asserted-by":"publisher","DOI":"10.1039\/C4NR01816H"},{"key":"e_1_3_5_136_2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201570303"},{"key":"e_1_3_5_137_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.3c06786"},{"key":"e_1_3_5_138_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c06599"},{"key":"e_1_3_5_139_2","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202308148"},{"key":"e_1_3_5_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-18843-5.00002-1"},{"key":"e_1_3_5_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-18843-5.00022-7"},{"key":"e_1_3_5_142_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.energyfuels.4c05473"},{"key":"e_1_3_5_143_2","doi-asserted-by":"publisher","DOI":"10.1515\/rams-2024-0075"},{"key":"e_1_3_5_144_2","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA06634H"},{"key":"e_1_3_5_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201902776"},{"key":"e_1_3_5_146_2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202501155"},{"key":"e_1_3_5_147_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.3c00247"},{"key":"e_1_3_5_148_2","doi-asserted-by":"publisher","DOI":"10.1021\/acssuschemeng.0c03781"},{"key":"e_1_3_5_149_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40097-022-00490-5"},{"key":"e_1_3_5_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asej.2024.102952"},{"key":"e_1_3_5_151_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S198353"},{"key":"e_1_3_5_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110695"},{"key":"e_1_3_5_153_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081291"},{"key":"e_1_3_5_154_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2019.1642420"},{"key":"e_1_3_5_155_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25194377"},{"key":"e_1_3_5_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2019.03.017"},{"key":"e_1_3_5_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.113858"},{"key":"e_1_3_5_158_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S96146"},{"key":"e_1_3_5_159_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S209325"},{"key":"e_1_3_5_160_2","doi-asserted-by":"publisher","DOI":"10.1021\/la202123e"},{"issue":"4","key":"e_1_3_5_161_2","first-page":"213","article-title":"Development and optimization of lipid-polymer hybrid nanoparticles containing melphalan using central composite design and its effect on ovarian cancer cell lines","volume":"20","author":"Mirnezami SMS","year":"2021","unstructured":"Mirnezami SMS, , Heydarinasab A, , Akbarzadehkhyavi A, et al. Development and optimization of lipid-polymer hybrid nanoparticles containing melphalan using central composite design and its effect on ovarian cancer cell lines. Iran J Pharm Res, 2021; 20(4):213\u2013228.","journal-title":"Iran J Pharm Res"},{"key":"e_1_3_5_162_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-021-00093-9"},{"key":"e_1_3_5_163_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01849-0"},{"key":"e_1_3_5_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2023.100165"},{"issue":"1","key":"e_1_3_5_165_2","first-page":"4","article-title":"Tacrolimus loaded lipid-polymer hybrid nanoparticles incorporated thermosensitive gel as intravesical drug delivery system","volume":"1","author":"Mohammad HA","year":"2022","unstructured":"Mohammad HA, , Ghareeb MM, , Akrami M, et al. Tacrolimus loaded lipid-polymer hybrid nanoparticles incorporated thermosensitive gel as intravesical drug delivery system. Maaen Journal for Medical Sciences, 2022; 1(1):4.","journal-title":"Maaen Journal for Medical Sciences"},{"key":"e_1_3_5_166_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030821"},{"key":"e_1_3_5_167_2","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2023.2204372"},{"key":"e_1_3_5_168_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.800481"},{"key":"e_1_3_5_169_2","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-21-144"},{"key":"e_1_3_5_170_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.1c02208"},{"key":"e_1_3_5_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121973"},{"key":"e_1_3_5_172_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S226798"},{"key":"e_1_3_5_173_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200116150426"},{"key":"e_1_3_5_174_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666201120155558"},{"key":"e_1_3_5_175_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36315"},{"key":"e_1_3_5_176_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2024.2318459"},{"key":"e_1_3_5_177_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1165662"},{"key":"e_1_3_5_178_2","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202400248"},{"key":"e_1_3_5_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.02.012"},{"key":"e_1_3_5_180_2","article-title":"Hybrid nanoparticles for cancer theranostics: A critical review on design, synthesis, and multifunctional capabilities","author":"Raka S","year":"2024","unstructured":"Raka S, , Belemkar S, , Bhattacharya S. Hybrid nanoparticles for cancer theranostics: A critical review on design, synthesis, and multifunctional capabilities. Curr Med Chem, 2024.","journal-title":"Curr Med Chem"},{"key":"e_1_3_5_181_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666171122103849"},{"key":"e_1_3_5_182_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1520274"},{"issue":"4","key":"e_1_3_5_183_2","first-page":"545","article-title":"Leveraging biomarkers and translational medicine for preclinical safety: Lessons for advancing the validation of alternatives to animal testing","volume":"41","author":"Hartung T","year":"2024","unstructured":"Hartung T, , King NM, , Kleinstreuer N, et al. Leveraging biomarkers and translational medicine for preclinical safety: Lessons for advancing the validation of alternatives to animal testing. ALTEX, 2024; 41(4):545\u2013566.","journal-title":"ALTEX"},{"key":"e_1_3_5_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2024.07.537"},{"key":"e_1_3_5_185_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49153-9"},{"key":"e_1_3_5_186_2","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.200601191"},{"key":"e_1_3_5_187_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn1006495"},{"key":"e_1_3_5_188_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm1013715"}],"container-title":["ASSAY and Drug Development Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/adt.2025.031","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/adt.2025.031","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/adt.2025.031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:28:58Z","timestamp":1777393738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/adt.2025.031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":187,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1089\/adt.2025.031"],"URL":"https:\/\/doi.org\/10.1089\/adt.2025.031","relation":{},"ISSN":["1540-658X","1557-8127"],"issn-type":[{"value":"1540-658X","type":"print"},{"value":"1557-8127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}